Macrocure Files Annual Report on Form 20-F for the Year Ended December 31, 2015

Apr 20, 2016, 07:00 ET from Macrocure Ltd.

PETACH TIKVA, Israel, April 20, 2016 /PRNewswire/ --

Macrocure Ltd. (NASDAQ: MCUR) ("Macrocure" or the "Company"), a clinical-stage biotechnology company, announced today that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2015 with the U.S. Securities and Exchange Commission (the "SEC"). The annual report on Form 20-F, which contains Macrocure's audited financial statements, can be accessed on the SEC's website at, as well as via the Company's investor relations website at The Company will deliver a hard copy of its annual report on Form 20-F, including its complete audited financial statements, free of charge, to its shareholders upon request to Shai Lankry, the Company's Chief Financial Officer, at +972-3-923-5556, or

About Macrocure Ltd. 

Macrocure Ltd. is a clinical-stage biotechnology company that until recently was focused on developing a novel therapeutic platform to address chronic and hard-to-heal wounds. For more information, please visit

For Investors: Shai Lankry Macrocure Ltd. +972-3-7631409

SOURCE Macrocure Ltd.